FDA — authorised 29 December 1992
- Application: NDA020262
- Marketing authorisation holder: HQ SPCLT PHARMA
- Local brand name: TAXOL
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Taxol in United States
FDA authorised Taxol on 29 December 1992
Marketing authorisations
FDA
- Status: approved
Taxol in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Taxol approved in United States?
Yes. FDA authorised it on 29 December 1992; FDA has authorised it.
Who is the marketing authorisation holder for Taxol in United States?
HQ SPCLT PHARMA holds the US marketing authorisation.